Clinical Trial Update: A Clinical Study Investigating Rifampicin and Dolutegravir in Combination in Healthy Volunteers [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating the combination of rifampicin and dolutegravir in healthy volunteers. It is sponsored by St. Stephens Clinical Resea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• Dolutegravir (dolutegravir)
• Rifampicin

Snippet

Sponsor: St. Stephens Clinical Research | Conditions: HIV-1-infection, Tuberculosis | Phase 1 | Status: UNKNOWN